0001415889-24-002611.txt : 20240205
0001415889-24-002611.hdr.sgml : 20240205
20240205173357
ACCESSION NUMBER: 0001415889-24-002611
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130201
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PICKERING GRANT
CENTRAL INDEX KEY: 0001258693
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39323
FILM NUMBER: 24597035
MAIL ADDRESS:
STREET 1: C/O VAXCYTE, INC.
STREET 2: 825 INDUSTRIAL ROAD, STE. 300
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxcyte, Inc.
CENTRAL INDEX KEY: 0001649094
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464233385
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD, STE. 300
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-837-0111
MAIL ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD, STE. 300
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
FORMER COMPANY:
FORMER CONFORMED NAME: SutroVax, Inc.
DATE OF NAME CHANGE: 20150724
4
1
form4-02052024_100248.xml
X0508
4
2013-02-01
0001649094
Vaxcyte, Inc.
PCVX
0001258693
PICKERING GRANT
C/O VAXCYTE, INC.
825 INDUSTRIAL ROAD, STE. 300
SAN CARLOS
CA
94070
true
true
false
false
CHIEF EXECUTIVE OFFICER
1
Common Stock
2024-02-01
4
S
0
119
71.934
D
151167
I
By Children's Trust
Common Stock
2024-02-01
4
S
0
491
73.255
D
150676
I
By Children's Trust
Common Stock
2024-02-01
4
S
0
443
74.366
D
150233
I
By Children's Trust
Common Stock
2024-02-01
4
S
0
255
75.473
D
149978
I
By Children's Trust
Common Stock
2024-02-01
4
S
0
134
71.931
D
151152
I
By Children's Trust
Common Stock
2024-02-01
4
S
0
655
73.341
D
150497
I
By Children's Trust
Common Stock
2024-02-01
4
S
0
238
74.562
D
150259
I
By Children's Trust
Common Stock
2024-02-01
4
S
0
281
75.486
D
149978
I
By Children's Trust
Common Stock
375814
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.
The price reported is a weighted-average price. The shares were sold at prices ranging from $71.69 to $71.94. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
The price reported is a weighted-average price. The shares were sold at prices ranging from $72.995 to $73.37. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $74.01 to $74.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $75.21 to $75.69. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $71.69 to $71.94. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares are held directly by a trust for the benefit of the Reporting Person's son.
The price reported is a weighted-average price. The shares were sold at prices ranging from $73.01 to $73.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $74.13 to $75.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $75.23 to $75.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Grant Pickering, by /s/ Andrew Guggenhime, Attorney-in-Fact
2024-02-05